Cargando...
Spotlight on fevipiprant and its potential in the treatment of asthma: evidence to date
Asthma is a heterogeneous disease, which may be classified into phenotypes and endotypes based on clinical characteristics and molecular mechanisms. The best described endotype of severe asthma is type 2 (T2)-high asthma, characterized by release of inflammatory cytokines by T helper 2 (T(H)2) cells...
Guardado en:
| Publicado en: | J Asthma Allergy |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6324611/ https://ncbi.nlm.nih.gov/pubmed/30662272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S167973 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|